In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Agendia files for and quickly withdraws IPO

Executive Summary

Agendia BV (molecular diagnostics for cancer) filed for its initial public offering and then withdrew it within a month, citing volatile market conditions. The company, which was spun off from the Netherlands Cancer Institute in 2003, was hoping to raise up to €90mm ($128mm) and use the proceeds to expand marketing of its products in the US.
Deal Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register